Citing unprecedented future demands on the Food & Drug Administration, a group of five Democrats in the House and Senate sent an open letter to U.S. Dept. of Health and Human Services secretary Kathleen Sebelius, urging her to boost the Food & Drug Administration’s budget for 2012.
“After years of inadequate budgets, FDA finally received real increases in fiscal years 2008, 2009, and 2010, which enabled FDA to restore the staffing losses incurred since the early 1990s,” the legislators wrote. “However, the FY 2011 budget for FDA barely kept up with inflation, and the agency is faced with far more problems and challenges than it had in 1994.”
The Aug. 4 letter was signed by Reps. Harry Waxman (D-Calif.), John Dingell (D-Mich.), Bart Stupak (D-Mich.), Frank Pallone (D-N.J.) and Sen. Tom Harkin (D-Iowa).
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Citing a myriad of recent FDA headlines, such as a heparin contamination episode in 2009 and a series of damaging news reports about the agency’s handling of its affairs, the group wrote that the federal watchdog has been “reduced to management by crisis” and is in danger of being perceived as a “failed agency” by the American public.
The delegation pushed Sebelius to do everything in her power to curb that perception by making sure the agency was adequately funded to meet its mandate.
Sebelius asked for a 23 percent increase to the FDA’s 2011 budget in February, to $4.03 billion.
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.